Opium Consumption and the Incidence of Cancer: Does Opium Account as an Emerging Risk Factor for Gastrointestinal Cancer?
- 95 Downloads
Some epidemiological studies have shown an association between opium consumption and the incidence of gastrointestinal (GI) cancer. The present study was designed to investigate the effects of opium on the initiation of GI cancer in rats.
Forty-five rats were randomly divided into three groups; each received different treatment for 40 weeks. The rats in group 1 received purified water, while animals in group 2 were treated with 5 mg/kg diethylnitrosamine (DEN) orally for 8 weeks and continued with purified water by the end of the experiment. The third experimental group received 300 mg/kg opium for 16 weeks and then continued with 50 mg/kg phenobarbital by the end of the 40th week. The growth of tumors in the treated groups was assessed by histological changes and the up/down expression of p53, cdkn1, cdk2, e-cdh, and n-cdh genes in different parts of GI tract.
Histological examinations revealed that DEN was able to induce the growth of tumor in GI tract as shown by active mitotic figure in different regions of GI system and hyperplasia of hepatocytes associated with infiltration of inflammatory cells, intestinal villous hypertrophy, and colorectal adenoma. There was also significant (p < 0.05) overexpression of p53, cdk2, and n-Cdh genes in different parts of digestive system in DEN-treated group. However, these pathological changes and the degradation of gene expression were not observed in the opium-treated group.
The results of this study suggest that the opium does not promote the initiation of cancer in GI tract.
KeywordsDiethylnitrosamine Opium Cancer Gastrointestinal tract
We would like to thank the Ministry of Higher Education and Scientific Research in Iraq and the University of Tehran for funding this study. Special thanks to Dr. Hossein Golami and Dr. Hassan Khalaf Al-Qaraghouli for preparation of some pathological pictures of tissues.
Compliance with Ethical Standards
The experimental protocol has been approved by the institutional Animal care and use Committee.
Conflict of Interest
The authors declare that they have no conflict of interest.
- 2.American Cancer Society. Cancer facts and figures. Atlanta, GA: Publisher American cancer Society. 2012. http://www.cancer.org/research/cancerfactfigures/cancer-facts-figure-2012:1-2.
- 3.Liao DJ, Blanck A, Eneroth P, Gustafsson JA, Hällström IP. Diethylnitrosamine causes pituitary damage, disturbs hormone levels, and reduces sexual dimorphism of certain liver functions in the rat. Environ Health Perspect. 2001;109(9):943–7. https://doi.org/10.1289/ehp.01109943.CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Aggrawal A. Opium: the king of narcotics. In: Aggrawal A, editor. Narcotic drugs. New Delhi: New Delhi National Book Trust; 1995. p. 161.Google Scholar
- 6.United Nations Office on Drugs and Crime (UNODC). World drug report 2010. United Nations Publication Sales No.10.XI.13; 2010:1–50.Google Scholar
- 8.Shakeri R, Kamangar F, Nasrollahzadeh D, Nouraie M, Khademi H, Etemadi A, et al. Is opium a real risk factor for esophageal cancer or just a methodological artifact? Hospital and neighborhood controls in case-control studies. PLoS One. 2012;7(3):e32711. https://doi.org/10.1371/journal.pone.0032711.CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Hosseini SY, Safarinejad MR, Amini E, Hooshyar H. Opium consumption and risk of bladder cancer: a case-control analysis. In: Urologic Oncology: Seminars and Original Investigations. Elsevier; 2010. vol 6, p. 610–616.Google Scholar
- 16.Sasamura T, Nakamura S, Iida Y, Fujii H, Murata J, Saiki I, et al. Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. Eur J Pharmacol. 2002;441(3):185–91. https://doi.org/10.1016/S0014-2999(02)01450-4.CrossRefPubMedGoogle Scholar
- 20.Sajadian S, Vatankhah M, Majdzadeh M, Kouhsari SM, Ghahremani MH, Ostad SN. Cell cycle arrest and apoptogenic properties of opium alkaloids noscapine and papaverine on breast cancer stem cells. Toxicol Mech Methods. 2015;25(5):388–95. https://doi.org/10.3109/15376516.2015.1045656.CrossRefPubMedGoogle Scholar
- 21.Hayes AW, Kruger CL. Hayes’ principles and methods of toxicology. Boca Raton: CRC Press; 2014.Google Scholar
- 22.Lijinsky W. Chemistry and biology of N-nitroso compounds. Cambridge: Cambridge University Press; 1992.Google Scholar
- 23.Sánchez-Pérez Y, Carrasco-Legleu C, García-Cuellar C, Pérez-Carreón J, Hernández-García S, Salcido-Neyoy M, et al. Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis. Cancer Lett. 2005;217(1):25–32. https://doi.org/10.1016/j.canlet.2004.07.019.CrossRefPubMedGoogle Scholar
- 24.Schmahl D. Combination effects in chemical carcinogenesis. In: Chambers PL, Klinger W, editors. Further studies in the assessment of toxic actions. Arch Toxicol Suppl. 1980;4:29–40.Google Scholar
- 28.Pawan M, Choudhary R, Mathur R, Choudhary M, Kamla M. Study on harmful effects of opium on liver and lungs in chronic opium addicts of western Rajasthan. Journal of Bangladesh Society of Physiologist. 2011;6(2):122–6.Google Scholar
- 33.El-Deiry W. P21/P53, cellular growth control and genomic integrity. Cyclin Dependent Kinase (CDK) Inhibitors. In: Current Topics in Microbiology and Immunology book series. 1998;227:121–137.Google Scholar
- 35.Zhu W, Abbas T, Dutta A. DNA Replication and Genomic. Genomic Advances in Experimental Medicine and Biology book series. 2005; 249–279.Google Scholar